Latest news
Targeted Therapy Resistance in NSCLC: Critical Next Steps - OncodailyOncodaily · Sun, 09 Aug 2026 15:22:32 GMTNew Research Explores the Cost of Managing Brain Metastases in ALK-Positive Lung Cancer - Oncogene Cancer Research - OncodailyOncodaily · Sat, 08 Aug 2026 22:09:53 GMTNVL-655: Mechanism, Dose, Administration, And Clinical Trials - OncodailyOncodaily · Sat, 08 Aug 2026 11:20:46 GMTChinmay Jani: AYA Lung Cancer Is Not the Same as Traditional NSCLC - OncodailyOncodaily · Fri, 07 Aug 2026 20:01:10 GMTInnovative Healthcare Institute Announces Program Highlights for Best of Lung Cancer Conference - OncodailyOncodaily · Fri, 07 Aug 2026 18:56:23 GMTHER2 Mutations in NSCLC: Critical Risks of Outdated Terms - OncodailyOncodaily · Fri, 07 Aug 2026 16:43:17 GMTEGFR Amplification in EGFR-Mutated NSCLC: Critical Risk Marker - OncodailyOncodaily · Wed, 05 Aug 2026 14:17:49 GMTPhase 2 Study Evaluates BIO 300 With SBRT in Early-Stage NSCLC and ILD - OncodailyOncodaily · Sun, 02 Aug 2026 15:27:55 GMT